Brokerages Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) Target Price at $30.18 - MarketBeat
11 hours ago • Google News
Nurix Therapeutics Inc (NRIX)
US$ 27.340.37%
Price Chart
Key Statistics
Market Cap
$ 942.27M
P/E Ratio
0.00
Revenue (TTM)
$ 56.42M
Volume
806.67K
52W High
$ 29.56
52W Low
$ 8.18
Dividend Yield
0.00%
Beta
2.16
Technicals
50-Day MA
11.1461
200-Day MA
17.1531
52 Week High
29.56
52 Week Low
8.18
About NRIX
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer,.
Employees
286
Headquarters
San Francisco, CA
CEO
Dr. Arthur T. Sands M.D., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg